Compare TPCS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TPCS | ICCM |
|---|---|---|
| Founded | 1956 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9M | 43.4M |
| IPO Year | N/A | N/A |
| Metric | TPCS | ICCM |
|---|---|---|
| Price | $5.04 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 43.7K | ★ 392.9K |
| Earning Date | 11-13-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $33,564,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | N/A | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.15 | N/A |
| 52 Week Low | $2.05 | $0.58 |
| 52 Week High | $6.25 | $1.66 |
| Indicator | TPCS | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 57.64 | 51.74 |
| Support Level | $4.86 | $0.58 |
| Resistance Level | $5.69 | $0.74 |
| Average True Range (ATR) | 0.31 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 42.48 | 64.81 |
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.